ABELCET

This brand name is authorized in United States. It is also authorized in Brazil, Canada, Croatia, France, Mexico, Netherlands, Poland, Spain, Turkey, UK.

Active ingredients

The drug ABELCET contains one active pharmaceutical ingredient (API):

1	Amphotericin B UNII 7XU7A7DROE - AMPHOTERICIN B
	Amphotericin B is a macrocyclic, polyene antifungal antibiotic produced by Streptomyces nodosus. The molecule is thought to act by binding to sterols in the fungal cell membrane, with a resulting change in membrane permeability, allowing leakage of a variety of small molecules.
	Read more about Amphotericin B

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J02AA01	Amphotericin B	J Antiinfectives for systemic use → J02 Antimycotics for systemic use → J02A Antimycotics for systemic use → J02AA Antibiotics
Discover more medicines within J02AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	525500605111312
CA	Health Products and Food Branch	02231590
ES	Centro de información online de medicamentos de la AEMPS	60945
FR	Base de données publique des médicaments	66207341
GB	Medicines & Healthcare Products Regulatory Agency	213026, 79837
HR	Agencija za lijekove i medicinske proizvode	HR-H-747381908
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	218M2000
NL	Z-Index G-Standaard	15016757
NL	Z-Index G-Standaard, PRK	38849
PL	Rejestru Produktów Leczniczych	100111765
TR	İlaç ve Tıbbi Cihaz Kurumu	8699783690168
US	FDA, National Drug Code	57665-101